ACTU

ACTUATE THERAPEUTICS, INC. ACTU

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$20.68M total
BIOS Capital Management, LP
$15.38M0.0%
Voss Capital, LP
$2.64M0.0%
VANGUARD CAPITAL MANAGEMENT LLC
$602.0K-1.8%
AQR CAPITAL MANAGEMENT LLC
$195.1K+370.3%
GEODE CAPITAL MANAGEMENT, LLC
$172.2K-50.7%
Texas Capital Bank Wealth Management Services Inc
$157.0K+8.5%
Palogic Value Management, L.P.
$153.0K0.0%
MILLENNIUM MANAGEMENT LLC
$147.9KNew
BlackRock, Inc.
$137.8K-78.9%
ABS Investment Management LLC
$112.0K--
ABS Direct Equity Fund LLC
$112.0K+46.4%
VANGUARD FIDUCIARY TRUST CO
$83.4K-12.9%
Rock Creek Group, LP
$60.1K0.0%
JANE STREET GROUP, LLC
$59.9KNew
HighTower Advisors, LLC
$55.8KNew
GOLDMAN SACHS GROUP INC
$54.3K+186.1%
SFMG, LLC
$50.5K0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$43.1KNew
BRIDGEWAY CAPITAL MANAGEMENT, LLC
$35.9K-24.2%
STATE STREET CORP
$33.4K-66.9%
NORTHERN TRUST CORP
$32.5K-78.3%
Mariner, LLC
$32.3KNew
Gleason Group, Inc.
$29.1K0.0%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
$28.3K-41.0%
Qube Research & Technologies Ltd
$23.3KNew
See all 64 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/ACTU

Earnings Per Share

13fpro.ai/company/ACTU

Loading ratio trend…

ACTU insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About ACTUATE THERAPEUTICS, INC. (ACTU): stock profile, AI score and financials

ACTUATE THERAPEUTICS, INC. (ACTU) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. ACTU is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of ACTU by reported 13-F value include BIOS Capital Management, Voss Capital, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. ACTU trades on the Nasdaq exchange and files with the SEC under CIK 1652935. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ACTU daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ACTUATE THERAPEUTICS, INC. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1652935 →